Empowering Innovation
OncoPatch, an innovative solution for non-melanoma skin cancer, was developed in collaboration with a leading medical research university. Avocet Communications played a pivotal role in partnering with both the university and OncoPatch’s team of doctors and researchers to bring this groundbreaking technology to market, by providing comprehensive branding, messaging, and strategic support.
Non-melanoma skin cancer affects millions annually. Traditional methods like Mohs surgery are invasive and inconvenient, necessitating a better, less traumatic alternative.
OncoPatch’s radioactive foil therapy offers one-of-a-kind, non-invasive treatment for non-melanoma skin cancers. To successfully launch this innovation, OncoPatch needed a strong brand identity, strategic messaging, and effective marketing tools to attract investors and healthcare providers.
At Avocet Communications, we believe in the power of partnership and human connection. Our team worked closely with OncoPatch to understand their vision and marketplace challenges. We embarked on a journey to create a people-first brand that resonated with both patients and healthcare providers. Our approach included:
Avocet Communications’ partnership with OncoPatch exemplifies how strategic branding, messaging, and marketing can successfully bring innovative medical solutions to market. By addressing key challenges and leveraging comprehensive support, OncoPatch is set to transform the treatment landscape for non-melanoma skin cancer.
© 2000-2024 Avocet Communications Company
Sign up for the StrategyCast Newsletter and receive a weekly marketing podcast episode, clips, resources, and more to help you master your marketing strategy.*